Sign in

CIK 0001662579

  • Non-accelerated filer
  • Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475617627
Phone
+1 617-231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$122,487
in 1 filing, $122K under 10b5-1 plans

Net −$122,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Adams Kendra −$122K Chief Financial Officer sold 12% of stake
Date Insider Transaction Shares Price Value Owned after
2024-06-20 DOWNEY BRUCE Director Grant or award · Stock Option (Right to Buy) +32,500 32,500
2023-06-15 DOWNEY BRUCE Director Grant or award · Stock Option (Right to Buy) +26,000 26,000
2022-06-22 DOWNEY BRUCE Director Grant or award · Stock Option (Right to Buy) +23,500 23,500
2021-06-15 DOWNEY BRUCE Director Grant or award · Stock Option (Right to Buy) +23,500 23,500
2020-10-06 DOWNEY BRUCE Director Conversion +237,148 237,148
2020-10-06 DOWNEY BRUCE Director Conversion +252,394 489,542
2020-10-06 DOWNEY BRUCE Director Conversion · Series A Preferred Stock −2,000,000 0
2020-10-06 DOWNEY BRUCE Director Conversion · Series B Preferred Stock −2,128,571 0
2020-10-01 DOWNEY BRUCE Director Grant or award · Stock Option (Right to Buy) +17,786 17,786

Page 1 of 1 · 9 trades